ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals Inc (APLS)

36.88
-0.17
(-0.46%)
Closed July 23 4:00PM
36.88
0.00
( 0.00% )
Pre Market: 4:01AM

Income Statement

Balance Sheet

Cash Flow

Quarter End Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 16.32M22.06M22.66M44.85M94.97M110.4M146.38M172.33M
Operating Income -148.62M-152.94M-164.05M-175.08M-120.44M-137.08M-84.52M-62.09M
Pre Tax Income -155.49M-190.82M-167.46M-177.5M-121.84M-140M-84.15M-66.25M
Net Income -155.98M-191.27M-165.99M-177.78M-122.04M-140.24M-85.58M-66.42M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -148.48M-152.84M-164.3M-175.36M-120.51M-137.68M-84.3M-62.59M
EBITDA -148.24M-152.54M-163.67M-174.66M-120.02M-136.62M-84.04M-61.65M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0000250.65M66.56M75.42M396.59M
Operating Income -27.28M-50.77M-127.93M-288.02M-213.73M-536.28M-594.61M-517.12M
Pre Tax Income -27.13M-51.01M-127.5M-304.71M-343.03M-746M-651.5M-523.5M
Net Income -27.13M-51.01M-127.5M-304.71M-344.87M-746.35M-652.17M-525.63M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.509-1.013-2.266-5.414-4.53-7.653-5.888-4.436
EBIT -27.13M-50.76M-128.04M-289.69M-214.23M-534.92M-594.9M-517.85M
EBITDA -27.28M-50.77M-127.93M-287.78M-213.09M-534.9M-593.06M-515.34M